12:00 AM
 | 
Jul 03, 2000
 |  BC Week In Review  |  Company News  |  Deals

Connetics, InterMune Pharmaceuticals Inc. deal

ITMN paid CNCT $5.2 million for rights to Actimunne interferon gamma that ITMN did not already own. Beginning with the quarter ended June 30, ITMN...

Read the full 103 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >